Co-Diagnostics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $4.5M | $71.2M | $43.0M |
| FY2021 | $25.6M | $160.0M | $88.6M |
| FY2022 | $8.6M | $123.1M | $23.0M |
| FY2023 | $9.3M | $95.3M | $14.9M |
| FY2024 | $9.7M | $63.6M | $2.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $4.5M | $71.2M | $43.0M |
| FY2021 | $25.6M | $160.0M | $88.6M |
| FY2022 | $8.6M | $123.1M | $23.0M |
| FY2023 | $9.3M | $95.3M | $14.9M |
| FY2024 | $9.7M | $63.6M | $2.9M |